Error: Could not add to watchlist. X

SEB Concept Biotechnology

+ Watchlist
BFGCBIO:LX
121.233
EUR
4.606
3.95%
As of 00:59:30 ET on 08/27/2015.
Fund Type
FCP
52Wk Range
85.523 - 139.620
1 Yr Return
36.63%
YTD Return
17.78%
Previous Close
116.627
52Wk Range
85.523 - 139.620
1 Yr Return
36.63%
YTD Return
17.78%
Fund Type
FCP
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
International
NAV (on 08/27/2015)
121.233
Total Assets (m EUR) (on 08/27/2015)
584.757
Inception Date
10/16/2000
Last Dividend (on 01/16/2015)
0.2021
Dividend Indicated Gross Yield
0.17%
Fund Managers
ULRIKA BERGMAN
Front Load Fee
5.00%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
1.50%
Expense Ratio
1.80%
Top Fund Holdings
Name Position Value % of Fund
Gilead Sciences Inc 554.60 k 58.28 m 9.23
Amgen Inc 415.30 k 57.22 m 9.07
Biogen Inc 141.92 k 51.45 m 8.15
Celgene Corp 387.50 k 40.25 m 6.38
Regeneron Pharmaceuticals Inc 75.28 k 34.46 m 5.46
Alexion Pharmaceuticals Inc 178.99 k 29.04 m 4.60
Mylan NV 471.65 k 28.73 m 4.55
Endo International PLC 304.58 k 21.77 m 3.45
Shire PLC 91.74 k 19.88 m 3.15
Jazz Pharmaceuticals PLC 119.70 k 18.92 m 3.00
Profile
SEB Concept Biotechnology is an open-end investment fund incorporated in Luxembourg. The Fund's objective is to achieve long-term capital appreciation. The Fund invests globally in equities and equity-related securities of issuers from the biotechnology sector.
ADDRESS
ST/S6, 106 40
Stockholm
PHONE
352-2-66-82-1 Tel